Abstract
The crosstalk in the functional interplay of the neuroimmune system is essential to ensure homeostasis preservation and health. Alzheimer’s disease (AD) can be understood in the context of aging of this neuroimmune communication. AD has an important genderdependent component and is benefitted by lifestyle strategies such as physical exercise, enriched environments and nutrition. Recently, the functional and redox state of peripheral immune cells has been proposed as a useful tool for measuring the progression of AD. The present review summarizes the relevance of the disruption of crosstalk among neurons, glial cells, immune mediators and cells from the very beginning of the prodromal stages of AD, when early BPSD symptoms have already started but cognitive function still seems apparently normal. The study of the role of neuroimmune system and how its disruption contributes to the onset of disease may help in understanding its biological mechanisms and in finding behavioral parameters and immunological biomarkers for the prodromic phases. Here we present results of 3xTg-AD mice from pre-morbid to early-stages of AD and how early BPSD-like symptoms correlate with changes in the organometrics of thymus and spleen that are indirect indicators of the immunological status. These functional relationships between behavioral and peripheral system also revealed the existence of differences between biological and chronological ages (an advanced biological age) since the prodromal stages. Overall, the data available suggest that the crosstalk between behavior (nervous) and immune system plays an important role since prodromal stages of AD.
Keywords: Behavior, Peripheral immune system, neuroimmunoendocrine communication, Alzheimer’s disease, Age.
Current Pharmaceutical Design
Title:Crosstalk between Behavior and Immune System During the Prodromal Stages of Alzheimer`s Disease
Volume: 20 Issue: 29
Author(s): Lydia Gimenez-Llort, Virginia Torres-Lista and Monica De la Fuente
Affiliation:
Keywords: Behavior, Peripheral immune system, neuroimmunoendocrine communication, Alzheimer’s disease, Age.
Abstract: The crosstalk in the functional interplay of the neuroimmune system is essential to ensure homeostasis preservation and health. Alzheimer’s disease (AD) can be understood in the context of aging of this neuroimmune communication. AD has an important genderdependent component and is benefitted by lifestyle strategies such as physical exercise, enriched environments and nutrition. Recently, the functional and redox state of peripheral immune cells has been proposed as a useful tool for measuring the progression of AD. The present review summarizes the relevance of the disruption of crosstalk among neurons, glial cells, immune mediators and cells from the very beginning of the prodromal stages of AD, when early BPSD symptoms have already started but cognitive function still seems apparently normal. The study of the role of neuroimmune system and how its disruption contributes to the onset of disease may help in understanding its biological mechanisms and in finding behavioral parameters and immunological biomarkers for the prodromic phases. Here we present results of 3xTg-AD mice from pre-morbid to early-stages of AD and how early BPSD-like symptoms correlate with changes in the organometrics of thymus and spleen that are indirect indicators of the immunological status. These functional relationships between behavioral and peripheral system also revealed the existence of differences between biological and chronological ages (an advanced biological age) since the prodromal stages. Overall, the data available suggest that the crosstalk between behavior (nervous) and immune system plays an important role since prodromal stages of AD.
Export Options
About this article
Cite this article as:
Gimenez-Llort Lydia, Torres-Lista Virginia and Fuente De la Monica, Crosstalk between Behavior and Immune System During the Prodromal Stages of Alzheimer`s Disease, Current Pharmaceutical Design 2014; 20 (29) . https://dx.doi.org/10.2174/1381612820666140130205500
DOI https://dx.doi.org/10.2174/1381612820666140130205500 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In Vivo Human Amyloid Imaging
Current Alzheimer Research Climate Changes and Human Health: A Review of the Effect of Environmental Stressors on Cardiovascular Diseases Across Epidemiology and Biological Mechanisms
Current Pharmaceutical Design Retinal Nerve Fiber Layer Thickness is Associated with Episodic Memory Deficit in Mild Cognitive Impairment Patients
Current Alzheimer Research Vascular Toxicity of Chemotherapeutic Agents
Current Vascular Pharmacology Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases
Current Alzheimer Research Senescence of the Brain: Focus on Cognitive Kinases
Current Pharmaceutical Design Hormone Replacement Therapy in Rheumatoid Arthritis
Current Rheumatology Reviews Cerebral Angiogenesis and Expression of Angiogenic Factors in Aging Rats after Exercise
Current Neurovascular Research Progressive Supranuclear Palsy: What Do We Know About it?
Current Medicinal Chemistry Amino Thiols, Detoxification and Oxidative Stress in Pre-Eclampsia and Other Disorders of Pregnancy
Current Pharmaceutical Design Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review
Current Pharmaceutical Design Selenium-Derivative Compounds: A Review of New Perspectives in the Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants
Endocrine, Metabolic & Immune Disorders - Drug Targets Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies
Medicinal Chemistry Relevance of the Vascular Effects of Insulin in the Rationale of its Therapeutical Use
Cardiovascular & Hematological Disorders-Drug Targets The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies
Current Neuropharmacology Nutraceuticals and their Novel Drug Delivery System: A Boon to Human Health
Current Nutrition & Food Science The Role of Renal Nerve Ablation for the Management of Resistant Hypertension and other Disease Conditions: Benefits and Concerns
Current Vascular Pharmacology Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology